Review

Published on 10 Oct 2022

Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential

in Cancer Immunity and Immunotherapy

Qin Han
Mengchen Wang
Xi Dong
Fei Wei
Yun Luo
Xiaobo Sun

Frontiers in Immunology

doi 10.3389/fimmu.2022.985815

4,576 views
7 citations

Original Research

Published on 10 Oct 2022

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

in Cancer Immunity and Immunotherapy

David Repáraz
Marta Ruiz
Leyre Silva
Belén Aparicio
Josune Egea
Elizabeth Guruceaga
Daniel Ajona
Yaiza Senent
Enrique Conde
Flor Navarro

Frontiers in Immunology

doi 10.3389/fimmu.2022.991311

2,415 views

Original Research

Published on 07 Oct 2022

Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Fangchao Zhao
Zengying Wang
Zhirong Li
Shiquan Liu
Shujun Li

Frontiers in Immunology

doi 10.3389/fimmu.2022.980508

4,468 views
7 citations

Original Research

Published on 07 Oct 2022

GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC

in Cancer Immunity and Immunotherapy

Huaying Xie
Tingting Yan
Xinxin Lu
Yueyao Du
Shuguang Xu
Yu Kong
Liangjie Yu
Jian Sun
Liheng Zhou
Jun Ma

Frontiers in Immunology

doi 10.3389/fimmu.2022.1033367

2,692 views
3 citations

Original Research

Published on 07 Oct 2022

A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses

in Cancer Immunity and Immunotherapy

Jia Li
Hao Qiao
Fei Wu
Shiyu Sun
Cong Feng
Chaofan Li
Wanjun Yan
Wei Lv
Huizi Wu
Mengjie Liu

Frontiers in Immunology

doi 10.3389/fimmu.2022.998140

6,063 views
3 citations

Original Research

Published on 07 Oct 2022

A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis

in Cancer Immunity and Immunotherapy

Liang Chen
Xueming Zhang
Qixiang Zhang
Tao Zhang
Jiaheng Xie
Wei Wei
Ying Wang
Hongzhu Yu
Hongkun Zhou

Frontiers in Immunology

doi 10.3389/fimmu.2022.1022420

8,881 views
6 citations

Review

Published on 07 Oct 2022

Lipids for CD8+ TILs: Beneficial or harmful?

in Cancer Immunity and Immunotherapy

Duojiao Wu
Yuwen Chen

Frontiers in Immunology

doi 10.3389/fimmu.2022.1020422

4,633 views
4 citations

Case Report

Published on 07 Oct 2022

Case report: Systemic muscle involvement as the primary clinical manifestation of chronic active Epstein–Barr virus infection: A case-based review

in Cancer Immunity and Immunotherapy

Shanfen Shi
Liangda Li
Cuiping Pan
Yandi Yang
Gun Chen
Yongping He

Frontiers in Immunology

doi 10.3389/fimmu.2022.1027859

3,158 views
1 citation

Original Research

Published on 07 Oct 2022

Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma

in Cancer Immunity and Immunotherapy

Ziquan Sun
Guodong Li
Desi Shang
Jinning Zhang
Lianjie Ai
Ming Liu

Frontiers in Immunology

doi 10.3389/fimmu.2022.988303

3,741 views
1 citation

Original Research

Published on 07 Oct 2022

A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patients

in Cancer Immunity and Immunotherapy

Jingsheng Yuan
Zijian Liu
Zhenru Wu
Lvnan Yan
Jiayin Yang
Yujun Shi

Frontiers in Immunology

doi 10.3389/fimmu.2022.990571

2,873 views
2 citations

Original Research

Published on 07 Oct 2022

TP53I13 promotes metastasis in glioma via macrophages, neutrophils, and fibroblasts and is a potential prognostic biomarker

in Cancer Immunity and Immunotherapy

Xinqi Ge
Manyu Xu
Tong Cheng
Nan Hu
Pingping Sun
Bing Lu
Ziheng Wang
Jian Li

Frontiers in Immunology

doi 10.3389/fimmu.2022.974346

4,170 views
3 citations

Original Research

Published on 07 Oct 2022

Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching

in Cancer Immunity and Immunotherapy

Shao-Wu Jing
Chang Zhai
Wei Zhang
Ming He
Qing-Yi Liu
Ji-Fang Yao
Rui Wang
Zi-Qiang Tian
Jun Wang
Jun-Feng Liu

Frontiers in Immunology

doi 10.3389/fimmu.2022.970534

3,045 views
12 citations

Original Research

Published on 07 Oct 2022

Integrated profiling of endoplasmic reticulum stress-related DERL3 in the prognostic and immune features of lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Lanlan Lin
Guofu Lin
Hai Lin
Luyang Chen
Xiaohui Chen
Qinhui Lin
Yuan Xu
Yiming Zeng

Frontiers in Immunology

doi 10.3389/fimmu.2022.906420

3,574 views
3 citations

Original Research

Published on 07 Oct 2022

Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer

in Cancer Immunity and Immunotherapy

Peng Liu
Shouzhen Chen
Xingzhe Gao
Hao Liang
Daqian Sun
Benkang Shi
Qiujie Zhang
Hu Guo

Frontiers in Immunology

doi 10.3389/fimmu.2022.1032907

2,580 views
6 citations

Original Research

Published on 07 Oct 2022

B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma

in Cancer Immunity and Immunotherapy

Ilona Hagelstein
Monika Engel
Clemens Hinterleitner
Timo Manz
Melanie Märklin
Gundram Jung
Helmut R. Salih
Latifa Zekri

Frontiers in Immunology

doi 10.3389/fimmu.2022.1002898

2,820 views
2 citations

Case Report

Published on 06 Oct 2022

Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy

in Cancer Immunity and Immunotherapy

Serena De Matteis
Beatrice Casadei
Ginevra Lolli
Michele Dicataldo
Francesco Barbato
Elisa Dan
Andrea Paccagnella
Barbara Sinigaglia
Clara Bertuzzi
Annalisa Arcari

Frontiers in Immunology

doi 10.3389/fimmu.2022.994731

2,080 views
1 citation

Navigation group

Articles

Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential

Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma

GLDC mitigated by miR-30e regulates cell proliferation and tumor immune infiltration in TNBC

A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses

A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis

Lipids for CD8+ TILs: Beneficial or harmful?

Case report: Systemic muscle involvement as the primary clinical manifestation of chronic active Epstein–Barr virus infection: A case-based review

Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma

A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patients

TP53I13 promotes metastasis in glioma via macrophages, neutrophils, and fibroblasts and is a potential prognostic biomarker

Comparison of neoadjuvant immunotherapy plus chemotherapy versus chemotherapy alone for patients with locally advanced esophageal squamous cell carcinoma: A propensity score matching

Integrated profiling of endoplasmic reticulum stress-related DERL3 in the prognostic and immune features of lung adenocarcinoma

Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer

B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma

Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy